| Literature DB >> 34066813 |
Małgorzata Fischer1, Anna Mertas2, Zenon Paweł Czuba2, Małgorzata Skucha-Nowak1.
Abstract
Microinvasive dentistry is based on the treatment of early carious lesions with the use of dental infiltrants. The commercially available Icon dental infiltrant does not contain any bacteriostatic component. An experimental preparation enriched with the missing component was synthesised. The aim of this study was to evaluate the cytotoxicity of the experimental preparation. Mouse fibroblasts of the L-929 lineage were used for the in vitro study. Cell morphology and viability were assessed. In the cytotoxicity analysis, it was shown that the experimental preparation (42.8 ± 10.3) after 24 h at two-fold dilution showed similar cytotoxicity to Icon (42.7 ± 8.8) (p > 0.05), while at four-fold dilution experimental preparation (46.7 ± 3.1), it was less toxic than Icon (34.2 ± 3.1) (p < 0.05). The experimental preparation has the potential to provide an alternative to the Icon commercial preparation. Further research is needed to evaluate the cytotoxicity of the experimental preparation over a longer period of time.Entities:
Keywords: antimicrobial properties; dental materials; infiltrants; metronidazole; polymers
Year: 2021 PMID: 34066813 PMCID: PMC8125919 DOI: 10.3390/ma14092442
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Comparison of the mean viability of L-929 cells (%) after 24 h of incubation with a 2-fold and 4-fold dilution of the extract of the experimental preparation and the Icon preparation.
| Mean Viability of Cell (%) | |||
|---|---|---|---|
| Preparation | 2-Fold Dilution | 4-Fold Dilution | |
| Experimental preparation | 42.8 ± 10.3 | 46.7 ± 3.1 | * |
| Icon | 42.7 ± 7.8 | 34.2 ± 3.1 | * |
| * | * | ||
* statistical significance.
Figure 1Comparison of mean viability of L-929 cells (%) after 24 h of incubation with a 4-fold dilution of the extract of the experimental preparation and the Icon preparation (p < 0.05). * statistical significance.
Figure 2(a) Plate with cultures of L-929 cells immediately after a 24 h incubation period with 2-fold diluted extracts of the test preparations. (b) MTT assay performed for cultures shown in image (a) (after formazan extraction with DMSO).
Figure 3(a) L-929 line cells after 24 h incubation with a 2-fold diluted 24 h extract of the experimental preparation, (b) L-929 line cells after 24 h incubation with a 2-fold diluted 24 h extract of the experimental preparation after MTT assay, (c) L-929 cells after 24 h incubation with 2-fold diluted 24 h Icon extract, (d) L-929 cells after 24 h incubation with 2-fold diluted 24 h Icon extract after MTT test. (e) Control culture of adhered L-929 cells, (f) control culture of adhered L-929 cells after MTT test.
Composition and percentage content of the experimental preparation.
| Component | Quantity (g) | Content (%) |
|---|---|---|
| TEGDMA | 3.75 | 75 |
| HEMA | 1.25 | 25 |
| PMMAn-MTZ * | 0.05 | 1 * |
| DMAEMA * | 0.05 | 1 * |
| CQ * | 0.025 | 0.5 * |
* Ratio to total mass of monomers. TEGDMA (triethylene glycol dimethacrylate, Fluka, Buchs, Switzerland); HEMA (2-hydroxyethyl methacrylate, Acros, Belgium, NJ, USA); PMMAn (2-(7-methyl-1,6-dioxo-2,5-dioxa-7-octenyl) trimellitic anhydride); MTZ (metronidazole, Acros, New Jersey, NJ, USA); DMAEMA * (N,N-dimethylaminoethyl methacrylate, Merck, Darmstadt, Germany); CQ * (camphorquinone, Aldrich, St. Louis, MO, USA).
Figure 4(Part 1) Scheme for obtaining 24 h extracts. (Part 2) Scheme for assessing cell viability.